Effects of MK-801 on bladder overactivity in rats with cerebral infarction

The Journal of Urology
Osamu YokoyamaMikio Namiki

Abstract

Our objective was to evaluate the underlying mechanisms of neurogenic voiding dysfunction following cerebral infarction. The left middle cerebral artery (MCA) was occluded using 4-0 monofilament nylon thread in male S-D rats. Cystometric examination was performed in unanesthetized and urethane-anesthetized rats through a catheter chronically implanted in the dome of the bladder. Bladder capacity of unanesthetized or urethane anesthetized rats was significantly reduced just after occlusion of the left MCA; 2 weeks after the occlusion, the capacity was less than half that in sham-operated rats. Intravenous administration of N-methyl-d-aspartate (NMDA) receptor antagonist MK-801 to the unanesthetized sham-operated rats led to a marked dose-dependent decrease in bladder capacity. Its administration to unanesthetized rats with cerebral infarction resulted in a slight decrease in bladder capacity. In the urethane-anesthetized state, the bladder capacity of the rats with cerebral infarction was significantly increased by MK-801, 0.1 mg./kg., without inhibiting the contraction pressure or increasing the amount of residual urine. A high dose (1 mg./kg.) of MK-801 was required to increase the bladder capacity of sham-operated rats. This ...Continue Reading

References

Aug 31, 1979·Brain Research·A D LoewyR P Baker
Apr 19, 1991·Brain Research·B S MalloryW C de Groat
Aug 2, 1990·European Journal of Pharmacology·N L Daló, A A Larson
May 27, 1991·Neuroscience Letters·M YoshiyamaW C de Groat
May 31, 1990·European Journal of Pharmacology·C A MaggiA Meli
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
Aug 1, 1989·Japanese Journal of Pharmacology·K MorikawaY Gomi
Nov 3, 1994·European Journal of Pharmacology·M YoshiyamaW C De Groat
Mar 3, 1994·The New England Journal of Medicine·S A Lipton, P A Rosenberg
Dec 4, 1995·European Journal of Pharmacology·M YoshiyamaW C De Groat
Nov 1, 1956·The Journal of Comparative Neurology·T C RUCH, P C TANG

❮ Previous
Next ❯

Citations

Nov 24, 1999·Urology·M YoshiyamaM B Chancellor
Apr 7, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Gen YamamotoKazuo Takahama
Nov 26, 2009·Canadian Journal of Physiology and Pharmacology·Gen YamamotoKazuo Takahama
Oct 27, 2007·Journal of the Chinese Medical Association : JCMA·Shing-Hwa LuLuke S Chang
Feb 9, 2006·British Journal of Pharmacology·Gordon McMurrayAlasdair M Naylor
May 10, 2007·BJU International·Hitoshi MasudaNaoki Yoshimura
Sep 24, 1999·The Journal of Urology·Y NakamuraH Kontani
Jun 9, 2020·Neurourology and Urodynamics·Matthew O FraserMitsuharu Yoshiyama
Apr 13, 1999·The American Journal of Physiology·O YokoyamaW C de Groat
Dec 12, 2002·Scandinavian Journal of Urology and Nephrology. Supplementum·Osamu YokoyamaMikio Namiki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.